Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion

被引:5
|
作者
Blanco-Lezcano, Lisette [1 ,2 ]
Alberti-Amador, Esteban [1 ]
Diaz-Hung, Mei-Li [1 ,2 ]
Gonzalez-Fraguela, Maria Elena [1 ,2 ]
Estupinan-Diaz, Barbara [1 ,2 ]
Serrano-Sanchez, Teresa [1 ,2 ]
Francis-Turner, Liliana [3 ]
Jimenez-Martin, Javier [4 ]
Vega-Hurtado, Yamile [1 ]
Fernandez-Jimenez, Isabel [1 ]
机构
[1] Int Ctr Neurol Restorat CIREN, Expt Neurophysiol Dept, Ave 25 15805 E-158 & 160, Havana 11300, Cuba
[2] Latinoamerican Sch Med, Km 3 1-2 Carretera Panamericana, Havana 19148, Cuba
[3] Tolima Univ, Expt Grp Expt Models Zoo Human Sci, Fac Sci, 42nd St, Barrio Santa Elena 730001, Parte Alta, Colombia
[4] Univ Otago, Otago Sch Med Sci, Dept Physiol, POB 913, Dunedin 9016, New Zealand
来源
BEHAVIORAL SCIENCES | 2018年 / 8卷 / 02期
关键词
pedunculopontine nucleus; substantia nigra pars compacta; tyrosyne hydroxylase; vesicular monoamine transporter 2; dopamine transporter; dopaminergic homeostasis;
D O I
10.3390/bs8020020
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: The degeneration of the pedunculopontine nucleus (PPN) precedes the degeneration of the nigral cells in the pre-symptomatic stages of Parkinson's disease (PD). Although the literature recognizes that a lesion of the PPN increases the vulnerability of dopaminergic cells, it is unknown if this risk is associated with the loss of capability of handling the dopaminergic function. Methods: In this paper, the effects of a unilateral neurotoxic lesion of the PPN in tyrosine hydroxylase (TH), vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) mRNA expression in nigrostriatal tissue were evaluated. Three experimental groups were organized: non-treated rats, NMDA-lesioned rats and Sham-operated rats. Results: Seven days after the PPN lesion, in nigral tissue, TH mRNA expression was higher in comparison with control groups (p < 0.05); in contrast, VMAT2 mRNA expression showed a significant decrease (p < 0.01). DAT mRNA expression showed a significant decrease (p < 0.001) in the striatal tissue. Comparing nigral neuronal density of injured and control rats revealed no significant difference seven days post-PPN injury. Conclusions: Findings suggest that the PPN lesion modifies the mRNA expression of the proteins associated with dopaminergic homeostasis at nigrostriatal level. It could represent vulnerability signals for nigral dopaminergic cells and further increase the risk of degeneration of these cells.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Increase of tyrosine hydroxylase and dopamine transporter mRNA levels in ventral tegmental area of male mice under influence of repeated aggression experience
    Filipenko, ML
    Alekseyenko, OV
    Beilina, AG
    Kamynina, TP
    Kudryavtseva, NN
    [J]. MOLECULAR BRAIN RESEARCH, 2001, 96 (1-2): : 77 - 81
  • [42] In Drug-Naive Parkinson's Disease Patients, Dopamine Transporter and Tyrosine Hydroxylase Expression Are Increased in Peripheral Immune Cells
    Gopinath, A.
    Mackie, P.
    Smith, A.
    Riaz, T.
    Hansen, C.
    Gittis, A.
    Bouchard, R.
    Schenwk, J.
    Hashemi, P.
    Buchanan, A. M.
    Gaskill, P. J.
    Nolan, R.
    Matt, S.
    Doty, A.
    Ramirez-Zamora, A.
    Okun, M.
    Streit, W. J.
    Khoshbouei, H.
    [J]. CELL TRANSPLANTATION, 2022, 31
  • [43] Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D-2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems
    Rots, NY
    Cools, AR
    Berod, A
    Voorn, P
    Rostene, W
    deKloet, ER
    [J]. BRAIN RESEARCH, 1996, 710 (1-2) : 189 - 196
  • [44] Tyrosine hydroxylase mRNA is increased in old age and norepinephrine uptake transporter mRNA is decreased in middle age in locus coeruleus of Brown-Norway rats
    Shores, MM
    White, SS
    Veith, RC
    Szot, P
    [J]. BRAIN RESEARCH, 1999, 826 (01) : 143 - 147
  • [45] Effect of Gingerol on Cisplatin-Induced Pica Analogous to Emesis Via Modulating Expressions of Dopamine 2 Receptor, Dopamine Transporter and Tyrosine Hydroxylase in the Vomiting Model of Rats
    Qian, Weibin
    Cai, Xinrui
    Wang, Yingying
    Zhang, Xinying
    Zhao, Hongmin
    Qian, Qiuhai
    Yang, Zhihong
    Liu, Zhantao
    Hasegawa, Junichi
    [J]. YONAGO ACTA MEDICA, 2016, 59 (02) : 100 - 110
  • [46] Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine β-hydroxylase in the locus coeruleus and adrenal glands of rats
    Zhu, MY
    Wang, WP
    Iyo, AH
    Ordway, GA
    Kim, KS
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 94 (03) : 828 - 838
  • [47] Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system
    Barroso-Chinea, Pedro
    Cruz-Muros, Ignacio
    Afonso-Oramas, Domingo
    Castro-Hernandez, Javier
    Salas-Hernandez, Josmar
    Chtarto, Abdelwahed
    Luis-Ravelo, Diego
    Humbert-Claude, Marie
    Tenenbaum, Liliane
    Gonzalez-Hernandez, Tomas
    [J]. NEUROBIOLOGY OF DISEASE, 2016, 88 : 44 - 54
  • [48] Angiotensin-(1-7) regulates tyrosine hydroxylase and norepinephrine transporter expression in neuronal cultures from spontaneously hypertensive rats
    Verrilli, M. A. Lopez
    Gironacci, M.
    [J]. JOURNAL OF HYPERTENSION, 2008, 26 : S34 - S34
  • [49] Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
    Chandler, Cassie M.
    Nickell, Justin R.
    Wilson, A. George
    Culver, John P.
    Crooks, Peter A.
    Bardo, Michael T.
    Dwoskin, Linda P.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2024, 228
  • [50] Vesicular monoamine transporter-2 and aromatic L-amino acid decarhoxylase enhance dopamine delivery following L-DOPA administration in parkinsonian rats
    Lee, WY
    Chang, JW
    Nemeth, NL
    Kang, UJ
    [J]. NEUROLOGY, 1999, 52 (06) : A346 - A346